Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
November 13, 2026
With a trial looming, Novo Nordisk Inc. has reached a settlement in Connecticut federal court with Griffin Health Services Corp. over claims that the pharmaceutical giant distributed insulin pens without adequate warnings to the Connecticut healthcare provider's nurses.
-
November 13, 2026
A Delaware vice chancellor on Thursday awarded nearly $8 million against the founder of kidney testing startup NephroSant Inc., finding that she concealed changes to its flagship product, destroyed company files and courted investors for a competing venture.
-
November 13, 2026
The Fifth Circuit on Friday upheld the dismissal of a False Claims Act suit brought by a former Ventavia Research Group LLC director who briefly oversaw clinical trials for Pfizer Inc.'s COVID-19 vaccine, after the federal government argued her challenge to the scientific integrity of the trials conflicted with public health policy.
-
November 13, 2026
A former Cravath Swaine & Moore LLP document processing specialist who has been charged with insider trading is eyeing a possible plea deal, according to a New York federal court filing docketed Friday.
-
November 13, 2026
Two Swiss-based health-related companies hit U.S. public markets on Friday after pricing initial public offerings that totaled $350 million, while another U.S. biotechnology startup reportedly delayed IPO plans.
See more Life Sciences news